A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol.
Phumin ChaweephisalTrai TharnpanichAphinya SuroengritPattramon AungbamnetPanya SeksarnDarintr SosothikulSupanun LauhasurayotinKanhatai ChiengthongHansamon PoparnPiti TechavichitPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
Native E. coli asparaginase-based protocol provides a compelling pharmacokinetic effect. Asparaginase activity and/or antibody testing is recommended for all cases especially in a relapsed patient, history of high accumulative dose of asparaginase or suspected allergic reaction. Patients with low asparaginase activity or allergy may benefit from switching to an alternative form of asparaginase to maintain treatment efficacy.